management of risk factors to evidence-based targets is essential. High awareness of health problems caused
due to change in lifestyle and optimal management of risk factors can improve the metabolic syndrome and
likely reduce the development of both diabetes and atherosclerosis and hence reducing the demand for the
atherectomy devices.
The major companies of the market include Bayer AG, Cardiovascular systems, St. Jude medical, Boston scientific
corporation, Abbott laboratories, C.R Bard Inc., Volcano Corporation. The competition in this market usually
depends on the technology used in manufacturing of the devices and also the pricing strategies. Medtronic’s is
leading competitor in peripheral atherectomy devices. Medtronic acquired Covedian in 2015 and is expected to
remain in the leading position however it will face increasing competition from cardiovascular systems Inc.
Market Segmentation
Atherectomy Devices Type Outlook (Market Revenue in USD Million, 2014 - 2025)
• Directional atherectomy devices
• Rotational atherectomy devices
• Orbital atherectomy devices
• Laser atherectomy devices
Atherectomy Devices Regional Outlook (Market Revenue in USD Million, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Middle East and Africa
• South Africa
See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/medical-devices